Log In
Print this Print this

buprenorphine/naloxone (Suboxone Depot)

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionDepot formulation of buprenorphine and naloxone
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsTreat opiate addiction
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today